Innventure projects $100M annual revenue run rate for Accelsius by year-end 2026, signals shift to self-funded growth (NASDAQ:INV)March 31, 2026
Share Facebook Twitter LinkedIn Pinterest Email Andlauer Healthcare GAAP EPS of C$0.44, revenue of C$169.1M
Innventure projects $100M annual revenue run rate for Accelsius by year-end 2026, signals shift to self-funded growth (NASDAQ:INV)March 31, 2026
Fathom projects Elevate and START to drive margin expansion to over 10% of transactions by year-end (NASDAQ:FTHM)March 31, 2026
